DE69329108D1 - Verfahren zur inaktivierung von viren - Google Patents

Verfahren zur inaktivierung von viren

Info

Publication number
DE69329108D1
DE69329108D1 DE69329108T DE69329108T DE69329108D1 DE 69329108 D1 DE69329108 D1 DE 69329108D1 DE 69329108 T DE69329108 T DE 69329108T DE 69329108 T DE69329108 T DE 69329108T DE 69329108 D1 DE69329108 D1 DE 69329108D1
Authority
DE
Germany
Prior art keywords
inactivating viruses
supercritical
inactivating
directed
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69329108T
Other languages
English (en)
Other versions
DE69329108T2 (de
Inventor
P Castor
D Lander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOENG Inc
Original Assignee
BIOENG Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOENG Inc filed Critical BIOENG Inc
Publication of DE69329108D1 publication Critical patent/DE69329108D1/de
Application granted granted Critical
Publication of DE69329108T2 publication Critical patent/DE69329108T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18Liquid substances or solutions comprising solids or dissolved gases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69329108T 1992-03-02 1993-03-02 Verfahren zur inaktivierung von viren Expired - Fee Related DE69329108T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84451392A 1992-03-02 1992-03-02
PCT/US1993/001916 WO1993017724A1 (en) 1992-03-02 1993-03-02 Viral inactivation method

Publications (2)

Publication Number Publication Date
DE69329108D1 true DE69329108D1 (de) 2000-08-31
DE69329108T2 DE69329108T2 (de) 2001-03-22

Family

ID=25292924

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69329108T Expired - Fee Related DE69329108T2 (de) 1992-03-02 1993-03-02 Verfahren zur inaktivierung von viren

Country Status (6)

Country Link
US (2) US5877005A (de)
EP (1) EP0629135B1 (de)
JP (1) JP4260877B2 (de)
AT (1) ATE194921T1 (de)
DE (1) DE69329108T2 (de)
WO (1) WO1993017724A1 (de)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE194921T1 (de) * 1992-03-02 2000-08-15 Bioeng Inc Verfahren zur inaktivierung von viren
FR2699408B1 (fr) 1992-12-21 1995-03-24 Bioland Procédé de traitement de tissus osseux et biomatériaux implantables correspondants.
FR2735372B1 (fr) * 1995-06-13 1997-09-05 Bioland Nouvelles utilisations d'un courant de dioxyde de carbone supercritique a titre d'agent antiviral
US5723012A (en) * 1993-12-09 1998-03-03 Bioland Uses for a current of supercritical carbon dioxide as an antiviral agent
AUPN030794A0 (en) 1994-12-22 1995-01-27 Aruba International Pty Ltd Discontinuous plasma or serum delipidation
US6149864A (en) * 1998-06-25 2000-11-21 Massachusetts Institute Of Technology Supercritical fluid sterilization method
CA2363271C (en) * 1999-12-27 2004-07-06 Kabushiki Kaisha Sr Kaihatsu Method and device for disinfection/sterilization of medical instruments
AUPQ846900A0 (en) * 2000-06-29 2000-07-27 Aruba International Pty Ltd A vaccine
US20090017069A1 (en) * 2000-06-29 2009-01-15 Lipid Sciences, Inc. SARS Vaccine Compositions and Methods of Making and Using Them
US7439052B2 (en) * 2000-06-29 2008-10-21 Lipid Sciences Method of making modified immunodeficiency virus particles
US7407663B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified immunodeficiency virus particles
US7407662B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified viral particles with immunogenic properties and reduced lipid content
JP2004532709A (ja) * 2001-06-25 2004-10-28 リピド サイエンスィズ インコーポレイテッド 流体から脂質を除去するための溶媒を用いたシステムおよび方法
US7033500B2 (en) * 2001-06-25 2006-04-25 Lipid Sciences, Inc. Systems and methods using multiple solvents for the removal of lipids from fluids
US6991727B2 (en) * 2001-06-25 2006-01-31 Lipid Sciences, Inc. Hollow fiber contactor systems for removal of lipids from fluids
US20060060520A1 (en) * 2001-06-25 2006-03-23 Bomberger David C Systems and methods using a solvent for the removal of lipids from fluids
EP1409108A4 (de) * 2001-06-25 2007-11-14 Lipid Sciences Inc Hohlfaserberührungssysteme zur entfernung von lipiden aus fluiden
US7033813B2 (en) * 2001-09-05 2006-04-25 Trevor P Castor Inactivated vaccines for aids and other infectious diseases
US7037524B2 (en) * 2001-10-03 2006-05-02 Herbalscience, Llc Oral delivery of a botanical
US7105185B2 (en) 2001-10-03 2006-09-12 Herbalscience, Llc Kavalactone profile
US7291352B2 (en) 2001-10-03 2007-11-06 Herbalscience Llc Methods and compositions for oral delivery of Areca and mate' or theobromine
US20050053678A1 (en) * 2001-10-03 2005-03-10 Gow Robert T. Methods and compositions for betel nut chewing gum
US7029707B2 (en) * 2001-10-03 2006-04-18 Herbalscience, Llc Method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same
US7001620B2 (en) 2001-10-03 2006-02-21 Herbal Science, Llc Kavalactone product
US20050069596A1 (en) * 2001-10-03 2005-03-31 Gow Robert T. Compositions and methods comprising kava and anti-anxiety compounds
US7008591B2 (en) * 2001-10-17 2006-03-07 Edwards Lifesciences Corporation Supercritical fluid extraction process for tissue preparation
WO2004017946A1 (en) * 2002-08-26 2004-03-04 Lipid Sciences, Inc. Treating alzheimers using delipidated protein particles
US20050037025A1 (en) * 2002-10-03 2005-02-17 Gow Robert T. Methods and compositions comprising kava and mate' or theobromine
US7777006B2 (en) 2002-12-31 2010-08-17 Csl Behring L.L.C. Method for purification of alpha-1-antitrypsin
US7393826B2 (en) 2003-07-03 2008-07-01 Lipid Sciences, Inc. Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
ES2547547T3 (es) * 2003-07-03 2015-10-07 Hdl Therapeutics, Inc. Enriquecimiento de lipoproteínas de alta densidad pre-beta
US6960803B2 (en) * 2003-10-23 2005-11-01 Silicon Storage Technology, Inc. Landing pad for use as a contact to a conductive spacer
US7294353B2 (en) * 2003-10-24 2007-11-13 Herbalscience, Llc Methods and compositions comprising ilex
US7279184B2 (en) * 2003-10-24 2007-10-09 Herbalscience, Llc Methods and compositions comprising Ilex
US20070231788A1 (en) * 2003-12-31 2007-10-04 Keyvan Behnam Method for In Vitro Assay of Demineralized Bone Matrix
EP1701729B1 (de) 2003-12-31 2018-05-02 Warsaw Orthopedic, Inc. Verbesserte knochenmatrixzusammensetzungen und verfahren
US7387749B2 (en) * 2004-02-20 2008-06-17 Wayne State University Method of delaminating aggregated particles with a coating agent in a substantially supercritical fluid
TWI302944B (en) * 2004-07-12 2008-11-11 Method for removing virus activity from biological materials
CN1318581C (zh) * 2004-07-13 2007-05-30 南玮实业股份有限公司 利用超临界流体去除冠状病毒活性的方法
US20060269928A1 (en) * 2005-05-27 2006-11-30 Aphios Corporation Compositions, methods and apparatus for supercritical fluid virus inactivation
CN101365499A (zh) * 2005-11-01 2009-02-11 骨骼技术股份有限公司 骨基质组合物和方法
KR20080005678A (ko) * 2006-07-10 2008-01-15 삼성전자주식회사 인쇄회로기판 및 이를 갖는 전자장치
WO2008157492A2 (en) 2007-06-15 2008-12-24 Osteotech, Inc. Osteoinductive demineralized cancellous bone
CA2690816C (en) * 2007-06-15 2016-12-06 Osteotech, Inc. Method of treating tissue
AU2008265850B2 (en) 2007-06-15 2014-06-26 Warsaw Orthopedic, Inc. Bone matrix compositions and methods
US9554920B2 (en) * 2007-06-15 2017-01-31 Warsaw Orthopedic, Inc. Bone matrix compositions having nanoscale textured surfaces
US20110054408A1 (en) * 2007-07-10 2011-03-03 Guobao Wei Delivery systems, devices, tools, and methods of use
US9358113B2 (en) * 2007-07-10 2016-06-07 Warsaw Orthopedic, Inc. Delivery system
CA2694854C (en) 2007-08-17 2016-09-27 Csl Behring Gmbh Methods for purification of alpha-1-antitrypsin and apolipoprotein a-i
EP2211921B1 (de) 2007-10-19 2013-12-25 Warsaw Orthopedic, Inc. Demineralisierte knochenmatrix-zusammensetzungen und verfahren
US8679176B2 (en) 2007-12-18 2014-03-25 Cormatrix Cardiovascular, Inc Prosthetic tissue valve
US8257434B2 (en) 2007-12-18 2012-09-04 Cormatrix Cardiovascular, Inc. Prosthetic tissue valve
US9011537B2 (en) * 2009-02-12 2015-04-21 Warsaw Orthopedic, Inc. Delivery system cartridge
US20100322943A1 (en) 2009-06-17 2010-12-23 Thomas Cantor Therapeutic and diagnostic affinity purified specific polyclonal antibodies
US8945895B2 (en) 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
US8845719B2 (en) 2011-05-27 2014-09-30 Cormatrix Cardiovascular, Inc Extracellular matrix material conduits and methods of making and using same
US8956566B2 (en) 2012-03-12 2015-02-17 Pure Biosolutions, Llc System and method for virus inactivation
WO2014004103A1 (en) 2012-06-29 2014-01-03 Emd Millipore Corporation Methods for inactivating viruses during a protein purification process
US8791054B2 (en) * 2012-09-27 2014-07-29 Halliburton Energy Services, Inc. Methods of converting an inactive biocide into an active biocide using a chemical reaction
CN107109322B (zh) * 2014-10-24 2021-04-06 建新公司 从消毒处理容器一体化连续分离流体流
EP3088006A1 (de) * 2015-04-28 2016-11-02 Bayer Technology Services GmbH Verfahren zur kontinuierlichen virusinaktivierung in einem mikroreaktor
JP2018082987A (ja) * 2016-11-25 2018-05-31 株式会社日立製作所 ウイルス不活化方法及びウイルス不活化装置
CN111868232B (zh) 2017-11-22 2024-05-28 Hdl治疗公司 用于对血浆处理系统的流体回路进行灌注的系统和方法
JP2021509894A (ja) 2017-12-28 2021-04-08 エイチディーエル セラピューティクス インコーポレイテッドHdl Therapeutics, Inc. ヒト血漿から抽出されたpre−β高密度リポタンパク質を保存および投与するための方法
RU2691983C1 (ru) * 2018-02-27 2019-06-19 Общество с ограниченной ответственностью "Матрифлекс" Способ очистки, модификации и стерилизации производных костной ткани и кожного матрикса с использованием сверхкритического флюида
US11878101B2 (en) 2018-03-30 2024-01-23 Asahi Kasei Medical Co., Ltd. Blood purification device and method for producing same
WO2021048221A1 (en) * 2019-09-09 2021-03-18 Valneva Austria Gmbh Inactivation process for viruses
WO2023063933A1 (en) * 2020-10-12 2023-04-20 Castor Trevor P Apparatus and method for inactivating viruses and pathogens in human plasma units
WO2022109430A1 (en) * 2020-11-22 2022-05-27 Castor Trevor P Sustained release inactivated vaccines
WO2023063932A1 (en) * 2021-10-12 2023-04-20 Castor Trevor P Continuous flow, high throughput apparatus and method for inactivating viruses and pathogens in human plasma

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE32695E (en) * 1979-04-12 1988-06-14 Dasi Industries, Inc. Method and apparatus for treating fluent materials
US4615886A (en) * 1983-08-31 1986-10-07 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Utilizing a halohydrocarbon containing dissolved water to inactivate a lipid virus
US4749522A (en) * 1985-10-31 1988-06-07 Angio-Medical Corporation Supercritical fluid extraction of animal derived materials
WO1991001367A1 (en) * 1989-07-20 1991-02-07 Bioeng, Inc. Supercritical fluid disruption of and extraction from microbial cells
ATE194921T1 (de) * 1992-03-02 2000-08-15 Bioeng Inc Verfahren zur inaktivierung von viren
US5667835A (en) * 1993-10-27 1997-09-16 Nippan Tansan Co., Ltd. Method for inactivating enzymes, microorganisms and spores in a liquid foodstuff
US5520943A (en) * 1993-10-27 1996-05-28 Nippon Tansan Co., Ltd. Method for modifying the quality of liquid foodstuff

Also Published As

Publication number Publication date
JPH07505071A (ja) 1995-06-08
DE69329108T2 (de) 2001-03-22
ATE194921T1 (de) 2000-08-15
WO1993017724A1 (en) 1993-09-16
EP0629135B1 (de) 2000-07-26
US5877005A (en) 1999-03-02
US6465168B1 (en) 2002-10-15
JP4260877B2 (ja) 2009-04-30
EP0629135A1 (de) 1994-12-21

Similar Documents

Publication Publication Date Title
DE69329108T2 (de) Verfahren zur inaktivierung von viren
DE3750437D1 (de) Verfahren, Apparat und System zur Wiedererkennung von Rundfunkausschnitten.
DE68921948T2 (de) System und Verfahren zur Erkennung und Behandlung von ventrikulären Arrhythmien.
DE3888205T2 (de) Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür.
DE3786840D1 (de) Vorrichtung und verfahren zur oberflaechenbehandlung mit plasma.
DE69435010D1 (de) Verfahren und stoffe für die behandlung von individuen, die infiziert sind mit intrazellulär infektiösen agentien
DE69525473T2 (de) Vorrichtung zur behandlung von blutgefässen
DE69010893T2 (de) Verfahren zur behandlung von koks sowie löschen desselben.
DE3885358D1 (de) Vorrichtung und verfahren zur behandlung des randes eines brillenglases.
DE3784188D1 (de) Verfahren zur behandlung von industriellen gasen, die schwefelverbindungen enthalten.
DE3781535D1 (de) Verfahren und vorrichtung zur aseptischen behandlung von lebensmitteln.
DE3788749D1 (de) Verfahren und Vorrichtung zur Feststellung von molekularen und ionischen Spezies.
DE3873094D1 (de) Verfahren zur aufbereitung von gas.
ATE126531T1 (de) Verfahren zur gewinnung von natürlich hergestelltem chymosin.
DE69300508D1 (de) Verfahren und Apparatur zur schnellen und berührungslosen Identifizierung von Holzarten.
DE68910928D1 (de) Verfahren und Vorrichtung zur zentrifugalen Behandlung von Flüssigkeiten.
DE59002221D1 (de) Verfahren und vorrichtung zur entsorgung von organischen daempfen, insbesondere von loesemitteldaempfen.
DE3775426D1 (de) Verfahren zur behandlung von gasoelen.
DE3667960D1 (de) Verfahren zur herstellung von halogen-magnesium-alanat und dessen verwendung.
ATA134593A (de) Verfahren und vorrichtung zur nachbehandlung von gebeizten stahlprodukten, insbesondere von gebeiztem c-stahl-warmband
DE3874672D1 (de) Verfahren zur oxydierung von thiolen, disulfiden und thiolsulfonaten.
DE69014501D1 (de) Verfahren zur Behandlung von Titanlegierung und damit hergestelltes Stück.
DE59002951D1 (de) Verfahren und vorrichtung zur vakuumbehandlung von metallen.
DE69011044T2 (de) Verfahren und Vorrichtung zur Behandlung von Abgas.
DE69008690T2 (de) Verfahren und Vorrichtung zur Bestimmung von aeroben Bakterien.

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee